Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Abstract: In physical-layer secret key generation, key generation performance is susceptible to hardware impairments (HIs), which can degrade channel reciprocity. Additionally, the security of ...

The most common downstream events included worsening kidney function, orthostasis, electrolyte abnormalities, and falls. HealthDay News — The potential downstream harms in the gabapentinoid ...

The analysis included 120 veterans (66 years and older) who potentially experienced the gabapentinoid-LD prescribing cascade. HealthDay News — The potential downstream harms in the gabapentinoid ...

TUESDAY, Dec. 9, 2025 (HealthDay News) -- The potential downstream harms in the gabapentinoid (gabapentin and pregabalin)-edema-loop diuretic (LD) prescribing cascade are commonly overlooked, ...

Furosemide, a highly protein-bound organic acid, promotes free water clearance and natriuresis by entering the proximal tubules of the kidneys and blocking the sodium-potassium-chloride ...

1. First intranasal loop diuretic approved by the FDA for heart, kidney, and liver disease patients. 2. Clinical trials showed comparable efficacy to intravenous dosing with more convenient outpatient ...

What Is Enbumyst, and Why Does It Matter? Enbumyst is a new nasal spray form of bumetanide (first approved by the FDA in 1983). It is a type of medicine called a loop diuretic (also known as a “water ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...

Corstasis Therapeutics, a biopharmaceutical company providing outpatient therapeutic options for patients with cardiovascular and renal disease, announced that the U.S. Food and Drug Administration ...

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated consistent efficacy and safety regardless of diuretic type or dose and reduced overall diuretic requirements in patients ...